However, the RAN-binding protein 2 (RANBP2) promotes the SUMOylation and degradation of CEBPα by directly interacting with this molecule, thus augmenting the carcinogenesis of HCC [20]. The gene discussed is RANBP2; the disease is hepatocellular carcinoma.